Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.
AstraZeneca’s Polyneuropathy Treatment Recommended for EU Approval
Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.
